Thompson Davis & Co’s iKang Healthcare Group, Inc. KANG Stock Holding History

Thompson Davis & Co’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-250	Closed	-$5K	–	831
2018 Q2	$5K	Hold	250	–	–	0.01%	525
2018 Q1	$5K	Buy	250 +125	+100%	+$2.1K	0.01%	502
2017 Q4	$2K	Buy	+125	New	+$1.81K	﹤0.01%	624

Other funds holding KANG

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return

Thompson Davis & Co's KANG Position: Q3 2018 in Review

Thompson Davis & Co sold out of iKang Healthcare Group, Inc. (KANG) in Q3 2018, closing a stake of 250 shares — an estimated $5K sold.

Thompson Davis & Co first reported a position in KANG in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q2 2018. 52 funds tracked by Wall St. Rank hold KANG as of Q3 2018.

Thompson Davis & Co reported no remaining iKang Healthcare Group, Inc. position as of Q3 2018 after selling out during the quarter.
Thompson Davis & Co sold 250 iKang Healthcare Group, Inc. shares in Q3 2018, an estimated $5K.
Thompson Davis & Co first reported a position in iKang Healthcare Group, Inc. in Q4 2017 and held it in 3 quarters.
Thompson Davis & Co's iKang Healthcare Group, Inc. position peaked at $5K in Q2 2018.
52 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.